Urinary Tract Infection
- Older Age, Prior AMR Risk Factors for Adverse Outcomes in Uncomplicated UTI
- Cefoxitin Effective for Extended-Spectrum ß-Lactamase E coli Urinary Tract Infections
- Cefepime/Enmetazobactam Noninferior for Complicated UTI
- Inappropriate Antibiotic Prescribing for Uncomplicated Cystitis Still Occurs
- Endometrial Cancer Ups Risks for UTI, Kidney Failure
- Travelers’ Diarrhea Significantly Increases UTI Risk
- Gut Dysbiosis Identified in Women With Recurrent UTI
- Patient Race May Be a Proxy for Other Factors in Predictive Models for UTI Risk in Children
- Zerbaxa Approved for Complicated Pediatric Intra-abdominal, Urinary Tract Infections
- Role of Race in Calculating UTI Risk in Children Reassessed
- Oral Tebipenem Effectively Treats Complicated UTI, Pyelonephritis
- Cefepime-Taniborbactam Bests Meropenem in Complicated UTI Trial
Conference Coverage
MORE MEETINGS
Clinical Tools
Powered by
Powered by 
